{
  "id": "upd-2026-ml6zqju7",
  "type": "update",
  "status": "rejected",
  "createdAt": "2026-02-03T19:27:41.551Z",
  "createdBy": "daemon",
  "reviewedAt": "2026-02-05T20:30:00.000Z",
  "reviewedBy": "claude",
  "appliedAt": null,
  "rejectionReason": "No existing test to update - performance data folded into new test entry mrd-30",
  "testName": "Quest Diagnostics Flow Cytometry MRD Blood Test for Myeloma",
  "testId": null,
  "changes": {
    "performance": {
      "sensitivity": "as sensitive as next-generation sequencing",
      "cancerType": "myeloma",
      "stage": null,
      "population": "ultrasensitive detection of residual disease"
    }
  },
  "source": "https://newsroom.questdiagnostics.com/press-releases",
  "sourceTitle": "Quest Diagnostics: Quest Diagnostics Flow Cytometry MRD Blood Test for Myeloma sensitivity as sensitive as next-generation sequencing",
  "confidence": 0.75,
  "snippet": "sensitivity: as sensitive as next-generation sequencing in myeloma"
}